Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000

American Journal of Epidemiology

Volumn 160, Issue 6, 2004, Pages 531-539

  Imperatore, Giuseppina ^a   Cadwell, Betsy L ^a   Geiss, Linda ^a   Saadinne, Jinan B ^a   Williams, Desmond E ^a   Ford, Earl S ^a   Thompson, Theodore J ^a   Narayan, K M Venkat ^a   Gregg, Edward W ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Blood pressure; Cardiovascular diseases; Cholesterol; Diabetes mellitus; Risk factors; Smoking

Indexed keywords

CHOLESTEROL;

CARDIOVASCULAR DISEASE;

ADULT; AGED; ARTICLE; BAYES THEOREM; BLOOD PRESSURE; CALCULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE DISTRIBUTION; AGED; BAYES THEOREM; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MARKOV CHAINS; MIDDLE AGED; MODELS, STATISTICAL; MONTE CARLO METHOD; NUTRITION SURVEYS; POPULATION SURVEILLANCE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEX DISTRIBUTION; SMOKING; UNITED STATES;

EID: 4544266119     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwh232     Document Type: Article

References (47)

1. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000;355:675-87.
2. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998;339:861-7.
3. Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-44.
4. Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
5. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA 1999;281:1291-7.
6. Dobson AJ. Relationship between risk factor trends and disease trends. Ann Med 1994;26:67-71.
7. Grundy SM, Pasternak R, Greenland P, et al. AHA/ACC scientific statement: assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 1999;34:1348-59.
8. National Center for Health Statistics. Plan and operation of the Health and Nutrition Examination Survey, United States - 1971-1973. Hyattsville, MD: National Center for Health Statistics, 1977. (Vital and health statistics, series 1: programs and collection procedures, no. 10b) (DHEW publication no. (PHS) 79-1310).
9. McDowell A, Engel A, Massey JT, et al. Plan and operation of the Second National Health and Nutrition Examination Survey, 1976-1980. Hyattsville, MD: National Center for Health Statistics, 1981. (Vital and health statistics, series 1: programs and collection procedures, no. 113).
10. National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Hyattsville, MD: National Center for Health Statistics, 1994. (Vital and health statistics, series 1: programs and collection procedures, no. 32) (DHHS publication no. (PHS) 94-1308) (GPO no. 017-022-01260-0).
11. National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-1994, reference manuals and reports. (CD-ROM). Hyattsville, MD: National Center for Health Statistics, 1996. (NHANES III examination data file documentation, catalog no. 76200).
12. National Center for Health Statistics. NHANES 1999-2000 data files. Hyattsville, MD: National Center for Health Statistics, 2002. (http://www.cdc.gov/nchs/about/major/nhanes/ NHANES99_00.htm). (Accessed June 5, 2003).
13. National Center for Health Statistics. National Health and Nutrition Examination Survey physician's examination procedures manual. Hyattsville, MD: National Center for Health Statistics, 1999. (http://www.cdc.gov/nchs/data/ nhanes/pe.pdf). (Accessed June 5, 2003).
14. Johnson CL, Rifkind BM, Sempos CT, et al. Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. JAMA 1993;269:3002-8.
15. Total serum cholesterol levels of adults 18-74 years. United States, 1971-1974. Vital Health Stat 11 1978;(205):1-31.
16. Myers GL, Cooper GR, Winn CL, et al. The Centers for Disease Control-National Heart, Lung, and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements. Clin Lab Med 1989;9:105-35.
17. Lipid Research Clinics Program. Manual of laboratory operations. VoI 1. Lipid and lipoprotein analysis. Bethesda, MD: National Institutes of Health, 1974; revised 1982. (DHEW publication no. (NIH) 75-628).
18. Carroll M, Sempos C, Briefel R, et al. Serum lipids of adults 20-74 years: United States, 1976-80. Vital Health Stat 11 1993;(242):1-107.
19. Bachorik PS, Wood PD, Williams J, et al. Automated determination of total plasma cholesterol: a serum calibration technique. Clin Chim Acta 1979;96:145-53.
20. Allain CC, Poon LS, Chan CS, et al. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
21. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995;26:60-9.
22. Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: a cooperative study. JAMA 1977;237:255-61.
23. The 1980 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1980;140:1280-5.
24. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46.
25. SAS Institute, Inc. SAS procedures guide, version 8. Cary, NC: SAS Institute, Inc, 1999.
26. Shah BV, Barnwell BG, Bieler GS. SUDAAN user's manual, release 8.0. Research Triangle Park, NC: Research Triangle Institute, 1999.
27. WinBUGS, version 1.4. Cambridge and London, United Kingdom: MRC Biostatistics Unit, Institute of Public Health (Cambridge), and Imperial College School of Medicine (London), 2003.
28. Gelman A, Carlin JB, Stern HS, et al. Bayesian data analysis. New York, NY: Chapman & Hall, 1995.
29. Pyörälä K, Pedersen TR, Kjekshus J, et al. Cholesterol lowering with simvastatin improves prognosis of diabetes patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997;20:614-20.
30. Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000;321:412-19.
31. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
32. Arnett DK, McGovern PG, Jacobs DR Jr, et al. Fifteen-year trends in cardiovascular risk factors (1980-1982 through 1995-1997): The Minnesota Heart Survey. Am J Epidemiol 2002;156:929-35.
33. Ford ES, Mokdad AH, Giles WH, et al. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 2003;107:2185-9.
34. Cleeman JI, Lenfant C. The National Cholesterol Education Program. JAMA 1998;280:2099-104.
35. Goldberg RB, Mellies MJ, Sacks FM, et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation 1998;98:2513-19.
36. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998;339:1349-57.
37. Elkeles RS, Diamond JR, Poulter C, et al. Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Baling, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study. Diabetes Care 1998;21:641-8.
38. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult treatment panel III). JAMA 2001;285:2486-97.
39. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317:703-13.
40. Hansson L, Zanchetti A, Carruthers SG, et al. Effect of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Study Group. Lancet 1998:351:1755-62.
41. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72.
42. Kannel WB, D'Agostino R, Cobb JL. Effect of weight on cardiovascular disease. Am J Clin Nutr 1996;63(suppl):419S-22S.
43. Wilson PW, D'Agostino RB, Sullivan L, et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002;162:1867-72.
44. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002;287:2570-81.
45. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med 1996;335:217-25.
46. Malmberg K, Yusuf S, Gerstein HC, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000;102:1014-19.
47. Massing MW, Henley NS, Carter-Edwards L, et al. Lipid testing among patients with diabetes who receive diabetes care from primary care physicians. Diabetes Care 2003;26:1369-73.